Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ENDO 2026
    • ADA 2026
    • ASCO 2026
    • AACE 2026
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ENDO 2026
    • ADA 2026
    • ASCO 2026
    • AACE 2026
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023

Table of Contents

September 01, 2007; Volume 74,Issue 9

From the Editor

  • You have access
    ECT: Bad reputation, but often effective
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 614;

    It may come as a surprise that psychiarists still use electroconvulsive therapy. Books and movies have not portrayed it in a flattering light.

Point and Counterpoint

  • You have access
    Interpreting the Courage Trial
    Deepak L. Bhatt, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 618-620;

    We are fortunate to have a point-counterpoint between Dr. William Boden, the principal investigator of the Clinical Outcomes Utilizing Percutaneous Coronary Revascularization and Aggressive Drug Evaluation (COURAGE) trial, and Dr. Dean Kereiakes, a leading interventional cardiologist.

Point

  • You have access
    Interpreting the Courage Trial
    William E. Boden, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 623-633;

    We found that as an initial management strategy in patients with stable coronary artery disease, percutaneous coronary intervention did not reduce the incidence of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy.

Counterpoint

  • You have access
    Interpreting the Courage Trial
    Dean J. Kereiakes, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 637-642;

    COURAGE had several problems, and tells us nothing new.

Perspective

  • You have access
    Screening for coronary heart disease: Has the time for universal imaging arrived?
    Michael S. Lauer, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 645-656;

    Screening for coronary heart disease by means of an imaging test is not supported by evidence and is not endorsed by professional societies or the US Preventive Services Task Force.

Medical Grand Rounds

  • You have access
    Ulcerative colitis: Responding to the challenges
    Jean-Paul Achkar, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 657-660;

    Aminosalicylates are the first-line therapy for patients with mild to moderate active ulcerative colitis. Infliximab is now approved for moderately to severely active ulcerative colitis in patients who have had an inadequate response to conventional therapy.

Review

  • Managing knee osteoarthritis before and after arthroplasty
    You have access
    Managing knee osteoarthritis before and after arthroplasty
    James Rosneck, MD, Carlos A. Higuera, MD, Nabil Tadross, MD, Viktor Krebs, MD and Wael K. Barsoum, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 663-671;

    Primary care physicians play a key role in the diagnosis and nonoperative management of knee osteoarthritis, including monitoring for problems in patients who have undergone knee replacement surgery.

Medical Grand Rounds

  • You have access
    Hypertension from Framingham to ALLHAT: Translating clinical trials into practice
    Daniel Levy, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 672-678;

    Most people with hypertension are still not being adequately treated. Newer drugs have not surpassed diuretics in efficacy and safety. Rather than trying to develop newer, more expensive agents, our priority should be to treat more patients and to treat them more aggressively.

Review

  • You have access
    Electroconvulsive therapy: What the internist needs to know
    Mayur Pandya, DO, Leopoldo Pozuelo, MD and Donald Malone, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 679-685;

    Despite its bad reputation, electroconvulsive therapy is safe and effective for treating a number of psychiatric disorders. For some patients, it is the only therapy that works.

Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 74 (9)
Cleveland Clinic Journal of Medicine
Vol. 74, Issue 9
1 Sep 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts

Jump to

  • From the Editor
  • Point and Counterpoint
  • Point
  • Counterpoint
  • Perspective
  • Medical Grand Rounds
  • Review
  • Medical Grand Rounds
  • Review
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
What screening approach could improve early detection of ‘at-risk’ metabolic dysfunction–associated steatohepatitis in my patients?
Sclerotic lesions in the metadiaphysis regions of the knee
Comfort care: Creating a plan for hospitalized patients and their families
Disseminated coccidioidomycosis masquerading as bacterial cellulitis
Potassium-competitive acid blockers: Clinical pearls and practical insights
KDIGO chronic kidney disease heat map: Let the colors be your guide!
Sex-specific risk factors for stroke in women: Focus on the 2024 AHA/ASA guideline
FINEARTS-HF: Improving outcomes in heart failure with preserved or mildly reduced ejection fraction
Iris roseola: A diagnostic clue in neurosyphilis
‘All that wheezes is not asthma’—a reminder that the physical examination
Treating perinatal mood and anxiety disorders: A call to action
Palatal mass with an overlying white lesion
Ogilvie syndrome (colonic pseudo-obstruction)
Alpha-1 antitrypsin deficiency: A persistently underrecognized condition
Westermark sign (focal oligemia) in pulmonary embolism

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2026 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire